Risk Factors and Outcomes for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia

McNerney, K. O., Fabrizio, V. A., Talleur, A. C., Si Lim, S., Dreyzin, A., Baggott, C., Vatsayan, A., Rossoff, J., Prabhu, S., Pacenta, H. L., Phillips, C. L., Talano, J.-A., Moskop, A., Verneris, M. R., Myers, D., Karras, N., Bonifant, C. L., Qayed, M., Hermiston, M. L., … Naik, S. (2023). Risk Factors and Outcomes for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia. Blood, 142(Supplement 1), 2133–2133. https://doi.org/10.1182/blood-2023-189921
Authors:
Kevin O. McNerney
Vanessa A. Fabrizio
Aimee C. Talleur
Stephanie Si Lim
Alexandra Dreyzin
Christina Baggott
Anant Vatsayan
Jenna Rossoff
Snehit Prabhu
Holly Pacenta
Christine L. Phillips
Julie-An Talano
Amy Moskop
Michael R. Verneris
Douglas J. Myers
Nicole Karras
Challice L. Bonifant
Muna Qayed
Michelle L. Hermiston
Prakash Satwani
Christa Krupski
Amy K. Keating
Susanne H.C. Baumeister
Vasant Chinnabhandar
Emily Egeler
Kevin J. Curran
Crystal L. Mackall
Theodore W. Laetsch
Liora M. Schultz
Swati Naik
Affiliated Authors:
Prakash Satwani
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Management of Febrile Neutropenia in Cancer Patients (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2023-189921
DOI:
10.1182/blood-2023-189921
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: